This brain enzyme could become a new weapon against Alzheimer’s disease - Futura, le média qui explore le monde
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
The research focuses on an enzyme known as IDOL, which naturally regulates protective receptors in the brain. By turning off the gene that produces this enzyme, investigators allowed those receptors to survive longer and clear unwanted proteins more effectively.
An enzyme that targets protective brain receptors
This article is an excerpt. To read the full content, visit the original source. Futura, le média qui explore le monde
Related articles
Memory stays strong in old age when this brain enzyme is active - Nature
Screening of mouse hippocampus cells (pictured) identified an enzyme whose production rose with age. Credit: Talley Lambert/Science Photo LibraryAn enzyme found in the brain could help to preserve cognitive resilience with advancing age, according to research in mice, humans and cells1. Researchers found that high levels of the enzyme are linked to low levels of inflammation in the brains of aged mice. They also showed that the enzyme boosts the growth of neurons in ageing brains. The findings were reported on 15 October in Nature Neuroscience. The enzyme seems to act “as a compensatory cognitive-resilience mechanism”, says study co-author Amar Sahay, a neuroscientist at Massachusetts General Hospital in Boston. “This is a fantastic, very thoughtful approach to get at what could be protecting neurons,” says Timothy Hohman, a neuroscientist and geneticist at the Vanderbilt Memory & Alzheimer’s Center in Nashville, Tennessee, who was not involved in the study.
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!